ClinicalTrials.gov
public full text
Public Domain
Alzheimer's Disease Research Center (ADRC) PET Component Study
The purpose of this study is to further engage and characterize Alzheimer's Disease Research Center (ADRC) participants through additional research opportunities, particularly PET imaging. Amyloid and Tau PET imaging will be collected in 24 participants per year, for a total of 120 participants over five years. All participants will be followed longitudinally, including through potential transitions from normal aging to mild cognitive impairment (MCI) and Alzheimer's disease and related dementias (ADRD).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Long-term impact of disclosing amyloid PET results to individuals with subjective cognitive decline.#161751
- Decrease in Sense of Smell and Associated Cognitive Decline in Parkinson's Disease#1171547
- Tau Tracer Comparison in Healthy Controls and Alzheimer's Disease Patients#915756
- Chronic pain as a risk factor for Alzheimer's disease pathology: a longitudinal ADNI study.#1097812
- Emerging directions in tauopathy research#626240
Record · ID 1320088
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive